Table 1 Participant demographics and clinical details (± Standard Deviation)
From: Self-evaluation in schizophrenia: an fMRI study with implications for the understanding of insight
| Â | Healthy controls. (HC; N = 8) | Schizophrenia patients (Sz; N = 11) | Group comparisons |
|---|---|---|---|
Mean Age (years) | 31 (±9) | 39 (±11) | NS |
Gender (Male%) | 3/5 (37%) | 7/4 (64%) | NS |
Mean Duration of Education (years) | 16 (±3) | 12 (±2) | t=3.63, p < .05 |
WASI IQ Score | 112.4 (±16.4) | 101.3 (±17.3) | F=4.21, p < .05 |
Digit span (forward + backward) (0–30) | 18.1 (±4.74) | 16.3 (±4.24) | NS |
Trail making test: | Â | Â | Â |
Ratio Score | 2.45 (±1.51) | 2.38 (±0.89) | NS |
Mean Duration of Schizophrenia (years) | - | 12 (±8) |  |
Patient Status(Inpatients/Outpatients) | Â | 4/7 (36%/64%) | Â |
Insight (SAI-E) Total: |  | 16.23 (±8.63) |  |
Illness Awareness |  | 6.64 (±4.01) |  |
Symptom Relabelling |  | 4.86 (±3.58) |  |
Compliance | - | 4.73 (±1.79) |  |
PANSS score (SD) |  | 82.0 (±16.4) |  |
- Insight (item G12) | - | 3.18 (±1.78) |  |